Clinical need

• Pioneering system protecting healthcare staff from surgical smoke secures place on NHS Wales framework
• Unlocking innovation in gastroenterology diagnostics
• Mayo Clinic Healthcare adds testing and treatment for people with inherited heart conditions  
• Regional Anaesthesia Device Demonstrated Live at Arab Health
• New podcast launched for people with arthritis
• Medovate partners with Medipex to support development of Yorkshire NHS-created medical device innovations
• ViroCell Biologics and Great Ormond Street partnership to dislodge gene and cell therapy ‘logjam’
• How AI is levelling the playing field when it comes to gender and healthcare
• New procedure enhances efficacy of human-hair sized stent
• HEE secures licence for innovative tracheostomy device
• Tecman launches sustainable PPE innovation to support NHS carbon reduction
• Getting cancer screening programmes back on track with AI and digitisation
• New medical device to improve prediction of preterm birth
• RCR unveils UK’s first standardised radiotherapy consent forms
• Partnership to improve the patient experience in cancer care
• Project using smart rings and watches to detect heart problems receives Heart Research UK grant
• New technology detects early-stage bowel cancer
• Acquired Brain Injury Ireland launches ‘Rehabilitation Anywhere’
• Midlands maternity triage system goes digital for nationwide use
• NICE approves second-line therapy for advanced breast cancer
• Perfecting Surgical Site Illumination with the new improved Q‑Flow 2021
• Althea launches Endoscopy Transformation Service
• World first – biological evidence reveals scalp cooling physically protects hair from chemotherapy
• Althea launches affordable COVID-19 rapid antigen tests
• COVID-19 response product to help reduce the spread of airborne disease
• Lightpoint Medical receives CE Mark for world’s first approved robotic gamma probe
• Jellagen launches JellaGel
• New COVID-19 RNA test gives accurate results within minutes
• Research reveals portable digital chest drainage systems could help minimise spread of COVID-19
• EKF introduces accurate quantitative COVID-19 antibody test kit
• Isohelix and Precision Genetics partner to expand COVID-19 testing using saliva collection technology
• EKF launches PrimeStore MTM pathogenic sample collection and transportation kit
• Cancer anti-sickness drug offers hope for hallucinations in Parkinson’s
• Medela’s portable medical surgical and airway suction devices offers safer alternative to piped vacuum systems
• Neuromod publishes results of large-scale tinnitus clinical trial
• Medovate’s anaesthesia device receives European CE regulatory approval
• Collaborations to meet unmet clinical needs in biomarker discovery and characterisation
• Case Study: How remote monitoring is improving access to primary care for care home residents
• Hologic highlights role in UK’s ongoing COVID-19 fight
• Surgical instrument manufacturer chosen to package and sterilise 1.92 million items of PPE
• Bender UK selected to support the NHS in their fight against COVID-19
• Glenfield Hospital implants the world’s smallest leadless pacemaker into a patient’s heart
• Developing a patient-friendly breath test for COVID-19
• EKF secures COVID-19 novel sample collection kit manufacturing and supply contracts
• New made-in-Wales blood test for coronavirus
• Air disinfection system offers dental practices protection against COVID-19
• Sheffield orthotic manufacturer makes face visors to protect frontline NHS staff
• Althea urge UK Trusts to contact them if they have broken or disused ventilators
• Medtronic shares design specifications to aid global ventilator production
• Life-saving breathing aids in development for the NHS
• Major study to improve diagnosis and treatment of fatal peritonitis infection
• Medovate to bring upper GI therapy device to market
• The Regenerative Clinic launches injections for knee osteoarthritis
• Scalp cooling offered free of charge to teenagers and young adults
• Medtronic receives CE Mark for neurostimulator
• Sky Medical Technology: transforming patient care
• Rapid test for STIs in development
• NICE approves palbociclib through Cancer Drugs Fund
• New combination for kidney cancer treatment
• Isabel Healthcare launches new and improved mobile versions of its digital tools
• Heart Research UK grant for technology to detect heart failure
• Clinical trial to treat psychosis in Parkinson’s patients
• Consumable management service enhances patient safety and traceability
• Launch of Eight Billion Minds to address unmet global mental health needs
• Cementless technology for knee replacements
• The UK’s med-tech ecosystem is thriving, with NHS support
• Antimicrobial coating to fight hospital-acquired infections
• Ipsen UK & Ireland launches new pre-filled syringe
• Innovative catheter receives “bacteria-phobic claim” approval
• New blood test for prostate cancer now available
• Wideblue develops ground breaking personal capnometer
• Innovative treatment for advanced prostate cancer
• State-of-the-art 3D mammography units installed at Derby Hospital
• Startup launches wearable drug-free painkiller and rehabilitator
• Doctors trained in diabetes care with VR
• World’s first blood test for endometriosis can detect up to 9 out of 10 cases
• World-first online lactation care support system unveiled
• Red Dot Award for urine testing system
• Report launched to accelerate medtech innovation entries
• Scientists take step forward in tackling lung disease
• New partners join dementia collaboration
• CE approval for heart rate monitor
• Call launched to find solutions to NHS unmet needs
• Trialling new tech to speed up diagnosis of viruses
• Collaboration to produce unique surgical implants
• Queen’s Award for ostomy care specialist
• Proton beam therapy approved by NHS Wales
• Technology pinpoints biopsies to detect prostate cancer
• New medtech firm drives innovation in oxygen delivery
• Collaboration for Alzheimer’s and Parkinson’s treatment
• Developing eye drops to treat a common sight loss condition
• Patients to become their own anaesthetists
• Final patient enrolled in MCG study
• Transporting drugs safely and securely

Events

• Medical Technology UK 2023
• GAMA Healthcare Showcases Infection Control Technologies at Arab Health
• Future Surgery returns as the flagship event for the surgical sector
• State-of-the-Art Operating Theatre to Feature Live and Simulated Surgery at Future Surgery 2022
• The Harley Street Medical Area (HSMA) Healthcare Conference
• Anglonordic Life Science Conference 2022
• BioWales in London – 9th March – Draft Programme Announced
• Med-Tech Innovation Expo
• Advamed – The MedTech Conference
• Welsh Health and Life Science Sector Celebrates Innovation and Collaboration
• Digital Health, AI & IVDs: Navigating the Changing Regulatory Landscape – Thursday 20th January 2022
• Top 10 highlights at this year’s Future Surgery 2021
• SEHTA & Psephos Biomedica – MDR Series of Webinars
• ABHI Event: Procuring for Outcomes in an Evolving NHS (September 16th)
• Microbiome Connect Gut Therapeutics returns in November
• SEHTA 2021 International MedTech Expo & Conference (October 8th)
• Med-Tech Innovation Expo (September 28-29th)
• SEHTA & Zegami Webinar: Understanding AI Bias – How it occurs & what to do about it (June 30th)
• Medilink Midlands Innovation Day 2021 (June 29th)
• SEHTA & Psephos Biomedica Webinars: Accessing your Target Market (May 26th/June 8th)
• SEHTA and Innovate UK Loan Briefing Webinar (May 11th)
• Medilink Webinar: The Investment Journey – Post Covid-19 (April 20th)
• 17th Annual Anglonordic Life Science Conference (May 25th-26th)
• Medilink East Midlands Innovation Day (March 25th)
• Medilink Midlands Webinar: AI – minefield or potential gold mine? (March 9th)
• Medilink Midlands Webinar: Technology Enabled Community Care – The future of health (March 3rd)
• Grow your international business with Medilink UK at Arab Health 2021
• MediWales Connects goes online for 2021
• Medilink Midlands Webinar: Getting your healthcare app reviewed and accredited (Feb 11th)
• MediWales & DTR Medical Webinar: Continuing ENT diagnosis throughout COVID-19 safely (Feb 24th)
• Medilink Midlands Webinar: Using government schemes to fund your innovation (Feb 10th)
• Medilink Midlands Webinar: How life sciences companies can use SEO & content to promote their website & drive leads (Feb 2nd)
• SEHTA Webinar: Clinical Evidence (Feb 25th)
• Working with the Welsh NHS: Market access and procurement event (Jan 21st)
• Medilink Midlands Webinar: The impact of Brexit – How has your business been affected? (Jan 20th)
• Medilink Midlands Webinar: The UKCA Mark – implications on medical devices and product import/export (Jan 14th)
• SEHTA Webinar: CE & UKCA Marking (Jan 14th)
• Medilink Midlands Webinar: Mental Health in the Workplace (Jan 13th)
• Webinar: Getting the most out of your IP budget (Nov 26th)
• Webinar: Regulation, Immigration and Research – What changes at the end of the year (Nov 23rd)
• Diagnostics virtual summit: Advancing the future of diagnostics (Oct 28th)
• Finalists shortlisted for Medilink UK Business Awards
• Webinar: Patent Box – Uncover the hidden value in your business (14th Oct)
• Medilink UK Healthcare Virtual Business Awards 2020 (8th Oct)
• Webinar: Brexit/UKCA Marking (3rd Dec)
• Webinar: Accessing the German HealthTech Markets (22nd Oct)
• Event: Sensors in Medicine 2020
• Webinar: Lifescience Industry Spotlight – Speakers confirmed
• Webinar: Life sciences opportunities in Wallonia, Belgium
• SEHTA’s 2020 International MedTech Expo & Conference goes online
• MediWales webinar series: LifeStories Live
• Webinar: How healthy is your business?
• Webinar: Building a health-economic model for the NHS
• Webinar: Rethinking how to work after COVID
• Researchers at Cambridge Science Festival reveal latest insights into the brain
• Med-Tech Innovation Expo and Medilink UK renew partnership
• Finalists announced for the Medilink East Midlands Business Awards
• SEHTA’s 1st International MedTech Expo & Conference
• Medilink East Midlands Innovation Day
• Exhibit at Rehacare 2019
• Medilink East Midlands to hold annual Innovation Day event
• Headline Sponsor announced for Medilink WM Awards
• Medilink North of England announce Awards
• UK HealthTech 2018
• Medilink add new exhibitions to international calendar

Future watch

• World’s First Drowning Manikin to Showcase at Arab Health
• Keeping patients safe: antipsychotic medication monitoring using a pocket-sized six lead ECG
• FUJIFILM Healthcare Europe launches a dedicated prostate fusion imaging platform
• Medovate secures HSA approval in Singapore for game-changing SAFIRA® system
• Pilot launched to support mental health patients in Wales
• National robotic assisted surgery programme to be established in Wales
• TensCare launches new breast pump offering greater comfort to ease difficulties of breastfeeding
• Clinicians Invited to Apply for Prestigious Scholars Programme
• The launch of The Metaversity and a Global Virtual Lecture in the Metaverse at Arab Health 2022
• Cell shipment and storage medium set to make personalised treatments more accessible
• Health app reducing stress and anxiety in children showcased at Arab Health
• Innovative AI tech empowering management of chronic conditions at Arab Health
• Wound care technology launches in Wales
• Novo Nordisk launches recycling initiative, PenCycle
• Competition winners set to drive innovations in health and social care
• Targeting a specific immune cell could protect against antibiotic-induced breast cancer progression
• Leading the charge towards sustainable healthcare
• Birmingham researchers confirm speed, simplicity and sensitivity for new COVID-19 test
• Aspirin to be trialled as part of new treatment for aggressive form of breast cancer
• North West medtech firm signs first major distribution agreement
• NICE gives green light to first targeted therapy for ‘Cinderella’ cancer
• Partnership to discover novel oral antiviral drugs to treat coronaviruses
• Breakthrough in tissue engineering as ‘shape memory’ supports tissue growth
• Novel HIV vaccine trial starts at Oxford
• Partnership to develop urine test for bladder cancer
• Anglia Ruskin to lead NHS entrepreneurship training
• New partnership to provide UK hospitals with location tracking solutions
• BIVDA launches Emerging from the Pandemic strategy paper
• Cell & Gene Collective launched to advocate for adoption of next generation medicine in the UK
• Reducing NHS anaesthetic gas emissions: BPR Medical and Medclair announce collaboration
• Zemax’s OpticStudio helps LightPath optimise solutions for medical industries
• Lifescience Industry magazine – the new edition is out now
• UK Contract Research Organisations – An overview of the current landscape
• Targeting essential protein could lead to new breast cancer treatments
• Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery
• NHS Innovation Accelerator fellowship awarded to Brain in Hand
• Anthony Nolan Cell & Gene Therapy Services and ONK Therapeutics announce collaboration
• The future of the UK’s life science industry post COVID-19
• Innovative urine test rules out endometrial cancer in up to 99% of cases
• AI-powered patient intelligence platform promises to revolutionise marketing for drug brands
• Pfizer’s investigational atopic dermatitis treatment receives EAMS positive scientific opinion from the UK MHRA
• ‘Brain on a chip’ project aims to revolutionise computing power
• Existing breast cancer drug offers new targeted treatment for triple negative breast cancer
• Neurodegeneration discovery could help prevent disability in multiple sclerosis
• Glasgow scientists working to develop new immunotherapy for breast cancer
• New biomaterials can be ‘fine-tuned’ for medical applications
• Swansea University developing world’s first COVID-19 ‘smart-patch’ vaccine that will measure effectiveness
• Pfizer and BioNTech achieve first authorisation in the world for a vaccine to combat COVID-19
• Magnetic brain waves to detect injury and disease
• Anti-COVID-19 nasal spray is ‘ready for use in humans’
• Oxygen-response protein increases risk of breast cancer spreading to the lung
• TherapeutAix teams up with Alderley Analytical and Peak Proteins to solve PK/PD challenges
• New mouth spray could benefit patients with painful genetic skin condition
• Researchers tackle surface transmission of COVID-19 in new partnership
• Hospital Direct (Marketing) signs exclusive distributor agreement for infection control solution
• Kidney cancer treatment option accepted for use in NHS Scotland
• Novel osteoarthritis medicine begins Phase II trial
• Accelerate supports the development of safer VR experiences in Healthcare
• Vaccitech receives grant for COVID-19 vaccine research
• New study describes which cancer patients are more vulnerable to COVID-19
• UK Biobank creates cloud-based health data analysis platform
• Moletest aims to revolutionise melanoma skin cancer screening with new test
• Digital health accelerator programme open for applications
• Linde Partners with US 3D Medlab to optimise 3D printing for medical devices
• COVID-19 lateral flow antibody test receives CE mark
• Funding awarded to develop new COVID-19 T cell immunity test
• University of Birmingham spinout company ChromaTwist named ‘one to watch’
• International study discovers three potential new targets for treating epilepsy
• PrecisionLife identifies 68 genes associated with high risk of severe COVID-19
• LUNAC Therapeutics selects XenoGesis as strategic drug discovery partner
• Sygnature expands capabilities with acquisition of Alderley Oncology
• Bleepa platform receives CE mark
• Sugars could be the key to an earlier, more accurate test for prostate cancer
• Senzer to create targeted anti-viral treatments for COVID-19
• Identifying COVID risk genes and drugs with potential to improve survival
• Partnership for development and distribution of COVID-19 vaccine candidate
• Collaboration on rapid diagnostic and mass screening test for COVID-19
• New partnership with AI specialist to help UCL accelerate coronavirus research
• The role of motion capture in biomechanical science
• Advent Life Sciences announces launch of two new cancer companies
• Medopad rebrands as Huma and acquires two tech startups
• Partnership to conduct data challenges and build COVID-19 information portal
• Validation process begins for COVID-19 home diagnostic test
• Vaccitech and Oxford University announce promising data on prostate cancer immunotherapy
• Birmingham researcher awarded £1.68m to fund research in intracranial hypertension
• New approach to cardiac patient care could save lives and prevent hospital admissions
• Putting continuous improvement at the heart of innovation
• Fujifilm offers Wales preview of new global tech
• Professor develops breath testing device for coronavirus diagnosis
• The digital future of healthcare – ID Medical
• Aseptika named medtech company to watch
• Researchers to investigate method of growing new blood vessels
• AI in healthcare sector in rude health
• Cresset joins consortium to develop novel therapeutics
• Collaboration to develop cancer immunotherapy
• New website to support and empower people with Haemophilia
• The future of spine surgery – highlights from Eurospine 2019
• Urology robot tech first for Harley Street
• Improving cardiac surgery benefits through key research
• Free webinars to help companies prepare for Brexit
• Pioneering project for Parkinson’s UK and Alzheimer’s Research UK
• New study reveals how to repair damaged DNA
• Case study – Preparing for Brexit with Morningside Pharmaceuticals
• Get Brexit Ready with Medilink UK’s free expert webinars
• First holistic support app developed by cancer patients for cancer patients
• Lightpoint Medical wins award for technological innovation
• Scientists reverse aging process in stem cells
• Algatech licenses innovative biotechnology
• New solution for manufacturers to advance production accuracy, efficiency and quality
• Lords launch new inquiry into healthy ageing
• Health tech pioneers come together to improve social wellbeing
• Operating theatre practitioner launches petition to ban ‘smoking’ in theatres
• Phase I/II asthma trial begins
• Research into importance of exercise in cancer care
• HeartFlow Planner leads to change in treatment strategy
• Smart vest in development for asthma treatment
• Sygnature Discovery announces collaboration with software firm
• CPI supports development of skin and oral cancer therapy
• Smell of skin could lead to early diagnosis for Parkinson’s
• Positive results for ‘bacteria-phobic’ catheter
• Bacteria-killing glass could combat hospital infections
• New collaborations to improve asthma treatment
• New AI to identify and predict cancer symptom clusters
• Improving diagnosis of abnormalities in developing babies
• Molecular profiling could catch lung cancer early
• NHS App begins public rollout
• Robots to perform spinal surgery
• Study identifies heart condition biomarkers
• Breathalyser trial for cancer diagnosis
• Investigating personalised breast cancer screening
• Assessing back pain with an app
• New nano tool for cancer testing
• Clinical trial for new depression treatment
• Faster access to groundbreaking medicines
• How to prepare for a ‘no deal’ scenario
• Update on Brexit
• Interactive textiles to support independent living
• Advanced Therapies Network accelerates novel treatments
• Finding natural alternatives to traditional insecticides
• Fresh thinking vital for mental health
• Home monitoring service launched

Going global

• Sygnature Discovery expands US presence with office in Bay Area biotech hub
• Medilink UK International Exhibition Calendar 2023
• Arab Health opportunities for UK cannula manufacturer Sterimedix
• Belgian economic mission to the United Kingdom
• Medilink UK supports over 60 companies at Arab Health 2022
• Integrated ‘smart’ peak flow meter showcased at Arab Health 2022
• UK HealthTech Pioneers Reunite at Arab Health 2022
• Showcasing UK HealthTech at Medica 2021
• UK health tech industry looks forward to reuniting at MEDICA 2021
• UK to explore the future of healthcare at Expo 2020 Dubai
• Partnership supports Indian companies with antibody development
• Applications open for ABHI US Accelerator 2022 cohort
• Singapore-UK team developing novel device to reduce chemotherapy side-effects
• Trio Healthcare accelerates international expansion plans
• Award winning S-Cath system to be used across Texas to improve patient safety
• UK Healthcare Pavilion partners with the Middle East Medical Portal as a gateway to the Middle East
• UK Healthcare Pavilion brings together the UK’s healthcare and life sciences sector
• Partnership to address health worker shortfall and strengthen women physician leaders across Ethiopia
• Medovate unites with Konica Minolta Healthcare Americas Inc. to promote best practice in regional anaesthesia
• Medovate secures TGA Approval in Australia
• Gentronix expands services to meet growing global demand
• Medovate signs exclusive agreement with Vygon to distribute regional anaesthesia device
• Applications closing soon for ABHI US Accelerator 2021 cohort
• Birmingham spinout announces collaboration to develop precision cancer treatments
• Sygnature assists New York Medical College in the fight against Covid-19
• Expanding HbA1c POC testing reach in Middle East & Africa
• XenoGesis wins Queen’s Award in recognition of export growth
• Middle Eastern success for pioneering Scottish SME
• The Christie works with Kenyan partners to improve cancer outcomes
• The AHSN Network supports UK innovators at Arab Health 2020
• UK innovations launched at Arab Health
• Ground-breaking paediatric cardiac surgery at Arab Health 2020
• Capnography mask showcased at leading US paediatric show
• Future-proof operating theatre technology launches at Arab Health 2020
• FDA clearance for AI-powered decision support system
• New advanced therapy for endometrial cancer granted US patent
• UK and China scientists developing new drugs to fight tuberculosis
• Invest Northern Ireland partner with ABHI at MEDICA 2019
• Arab Health 2020 – Last few spaces on the ABHI UK pavilion
• UK digital healthtech companies to showcase at Medica 2019
• ABHI host UK Pavilion at Medical Fair Thailand
• Expanded ABHI US Accelerator provides a hit for UK healthtech
• BBI Solutions to showcase mobile diagnostics solutions at AAC
• ABHI US Accelerator enters next phase
• ABHI leadership team to share industry knowledge at MEDICA
• Magnetic blood filter granted US patent
• Exhibit at the world’s largest healthcare exhibition with Medilink
• ABHI supports UK healthtech sector in China
• Transatlantic trade opportunities for Midlands life science companies
• AHSNs join forces with ABHI at MEDICA
• Huddersfield firm that helps cancer patients keep their hair enters Japan
• Record sales for ABHI UK Pavilion at Arab Health 2020
• ABHI ensures Texas is go-to state for UK HealthTech success stateside
• Success of inaugural HealthTech Nordic programme
• Study to explore digital COPD treatment in Japan
• Cross-channel partnership for hearing loss and tinnitus
• Programme that prevents skiing accidents launched at Arab Health
• Cutting-edge surgery showcased at the ABHI UK Pavilion
• Digital urine test launched at Arab Health
• CHAPPER healthcare unveils European expansion at Arab Health
• Genetics testing company joins Innovation Hub
• Suction range highlighted at Arab Health
• Scalp cooling system to be showcased at Arab Health
• UK-Japan partnership to tackle degenerative diseases
• UK digital companies at Arab Health
• US Accelerator to target Tennessee
• Royal pharmacy to launch Middle Eastern service
• UK healthtech mission to Texas
• ABHI doubles its US Innovation Hub
• ABHI expands US Innovation Hub
• Paraid showcase updated ambulance chair at MEDICA 2018
• UK companies showcase life-saving healthtech solutions at MEDICA 2018
• Swansea University technology set to revolutionise Australian healthcare
• Creo Medical secures European distribution agreements
• Derby medical devices firm to spearhead UK-Texas trade deal
• Life science sector collaboration for the Midlands and Ohio

Money

• Free Tax and Legal Advice for Life Science Companies
• Deloitte’s research finds pharma R&D return on investment rises to highest level since 2014
• Baseimmune closes $4.8m funding round to future-proof vaccines 
• BIVDA Comments on Autumn 2021 plans for Life Sciences and UK Diagnostics
• Occuity raises over £2m to deliver ophthalmic and optical diabetes devices
• SolasCure receives £15m investment
• Medtech spinout behind new material for 3D printed implants raises £1.6m
• Biotech firm that ‘could revolutionise woundcare’ raises £1.8m
• GeneFirst awarded €2.8m funding for rapid Covid-19 diagnostic
• Ostomy specialist secures funding from US healthcare financier
• $8 million funding for commercial launch of robotic cancer detection probe
• Faciliflow device receives funding to prevent lymphoedema in cancer patients
• Foresight invests £300k from the Midlands Engine Investment Fund into ReadyGo Diagnostics
• Kidney research charity funds plan to improve patient treatment
• Heart Research UK pledges over £500,000 for COVID-19 research
• Oxford Brain Diagnostics wins funding to test Alzheimer’s diagnostic in the NHS
• University of Birmingham spinout lands funding for rapid development of fluorescent dyes
• HexagonFab secures £1.9m seed funding to launch the Bolt
• Antibiotic Research UK launches £200,000 small research grants programme to tackle antibiotic resistance
• Draper & Dash receives £2m investment to fuel rapid expansion
• Maven Equity Finance leads £2m funding round in chemical technology company
• MedTech NAVIGATOR funds six ground-breaking projects
• UK charity announces £1.2 million funding to design Parkinson’s drug
• Pathios Therapeutics boosted by Innovate UK funding
• Cancer diagnostics firm completes £3.5M funding round
• University of Birmingham spinout secures £800k for point of care diagnostics platform
• Phenotypeca raises £300,000 seed investment
• Vinehealth secures £1m Innovate UK Grant to improve cancer patient self-management and data collection
• Onyx Health launches national competition for life science SMEs
• Stream Bio wins SBRI Healthcare funding to develop test for heart attack biomarkers
• University spin-out fund makes half a million pound first investments
• Brain in Hand wins SBRI Healthcare Award to improve self-directed support services for autistic people
• Myricx Pharma launches with £4.5m financing to progress its novel NMT inhibitors in cancer
• £1m deal helps Talking Medicines scale-up data tech platform
• MedTech NAVIGATOR’s Innovation Grants boost funding for pioneering SMEs
• Medtech Accelerator awards £125,000 for innovative cervical screening patch
• Funding boost for AI-based epilepsy monitoring
• Heart Research UK grant for Ulster University project
• Maven co-leads £3.4m funding round for Gen inCode
• Innovate UK grant for next-generation tumour ablation treatment
• New fund to protect IP of North East health and life sciences businesses
• Intelligens awarded Innovate UK funding to model Covid-19 data
• Pneumagen announces £4m fundraising and commits to clinical trial development for COVID-19
• Health Enterprise East launches Innovation Grant funding for SMEs
• Boost for self-monitoring device for chemotherapy patients
• Digital Science reveals winners of its Catalyst Grant award
• Health Enterprise East launches MedTech NAVIGATOR with £1m grant
• Project to eliminate ‘zombie cells’ receives Heart Research UK funding
• Should the East Midlands be claiming more in R&D tax relief?
• Project to predict cardiovascular events receives Heart Research UK grant
• Valo Therapeutics announces new funding for immuno-oncology trials
• Contract research firm set to double in size
• Alantra advises on Synova’s investment in Charnwood Molecular
• Pinpoint secures new investment to develop ImpactAir Range
• £4.5 million collaboration to back health innovations for patients
• Oxford Drug Design wins grant and boosts funding
• Spin-out offering new hope for dialysis patients raises £2.75m
• Medical firm secures £1.4m for dry eye treatment
• BioCity backs promising self care venture
• BioCity invests in early-stage precision medicine biotech
• Medtech Accelerator awards £150k to ground-breaking innovations
• Charities pump £3 million into UK brain bank
• Researcher wins £60,000 funding to aid biomaterial research
• Funding awarded to mental health and surgical innovations
• University researcher wins funding to improve lung cancer detection
• Charity invests £1 million to develop Parkinson’s treatment
• Support for South East Midlands life science firms
• Funding for specialist in back and posture care products
• Funding awarded to pioneering software
• University spin-out secures £1.2m for new brain cancer test
• Funding awarded to breakthrough digital health technologies
• Million pound effort to tackle Lewy body dementia
• Funding to fight hospital acquired infections
• Investment in world’s first scalp cooling R&D centre
• Funding for bioimaging molecular probes
• Medtech grants now available in Leicester and Leicestershire
• Funding for stylish stoma products
• £2.17m boost for pancreatic cancer research
• £430k for pioneering, early stage technologies
• Research into patient experience of cell therapies
• £1.5m grant for gene therapy collaboration
• Funding boost for medicines manufacturing
• Investment for innovative diabetic footcare device
• Key points from the Budget 2018
• Digital start-up secures further investment
• Welsh life sciences company expands team after record funding
• SBRI Healthcare fast tracks cancer diagnostic inventions with £3.8m funding

People & places

• Bruntwood SciTech set to invest £60m into Manchester Science Park
• 60,000 Packs of Essential Medicines Donated to Ukraine
• PEP Health selected to take part in first-ever AWS Healthcare Accelerator
• Roland Kreissig appointed Oncology General Manager, Novartis UK and Ireland
• Coventry University transforming careers with apprenticeships
• Demand for life science business space in London increases four-fold
• Medilink UK Healthcare Business Awards
• Queen Elizabeth Hospital King’s Lynn device awarded HSJ Patient Safety Innovation of the Year
• Medics.Academy Chief Product Officer nominated for an Inspiring Fifty UK 2021 award
• Medicines Discovery Catapult relaunches Wolfson Radiochemistry facility in Manchester
• HLA:IDEAS student receives award for promoting diversity in medicine
• Double winners at the Medilink Midlands Business Awards
• New Director appointed to SEHTA Board
• Finalists announced for the Medilink Midlands Business Awards 2021
• Bollé partners with Welsh manufacturer for protective eyewear production
• Oral and maxillofacial centre of excellence opens in London
• The London Clinic advances robotic offering with latest da Vinci Xi Surgical System
• New CEO announced for SEHTA
• Boyds launches recruitment drive following surge in growth
• Sustainable £7M STEM facility completes in Bristol
• National innovation call launched to address LGBT+ health inequalities
• Global drug delivery company seals deal to expand operations at Charnwood Campus
• Intensive learning academies launched to help Wales’ health and care system meet the challenges of tomorrow
• Platinum Level Innovator Status awarded to Fusion Antibodies for pioneering technologies
• Sygnature Discovery creates second integrated drug discovery site at Alderley Park
• Transforming careers with apprenticeships at Coventry University
• Ireland’s first private ‘Rent a Lab’ incubator space for the life sciences sector opens
• Cleanroom microbiology supplier celebrates 50-year anniversary
• Cervical cancer treatment world first at The Christie
• Recognition for Sheffield scientists involved in Lighthouse Labs project
• UK ostomy specialist enjoys record year
• Guy’s and St Thomas’ NHS Foundation Trust partners with Civica
• EKF opens larger facility to increase production of key component for COVID-19 testing regime
• Portview completes new Covid testing lab for Health Services Laboratories & UCL
• Testing lab data reveals spread of new COVID variant
• Queen’s pharmacist chosen as COVID-19 vaccination site
• Greater Manchester Surgical Cancer Hub shortlisted for COVID-19 award
• Medilink Midlands CEO and Board Announced
• Welsh life science innovators receive awards for Covid-19 response
• Charnwood Lighthouse Lab goes live processing thousands of COVID-19 tests per day
• Coordinated industry response to Covid-19 provides major boost to Welsh economy
• The London Clinic becomes the UK’s first hospital to introduce AI device for colonoscopy
• Construction starts on the Medicines Manufacturing Innovation Centre
• HDR UK to lead 10,000 Black Interns Health Data Science Programme
• Blackpool Victoria Hospital introduces portable chest drainage as part of COVID-19 prevention measures
• Winners announced at the Medilink UK Healthcare Business Awards
• Morningside launches ambitious growth plans with appointment of new CEO and Chairman
• Sygnature Discovery expands DMPK capabilities with acquisition of XenoGesis
• Paxman Facebook Live Series provides beacon of light for UK cancer patients during COVID-19
• Welsh manufacturer set to double workforce thanks to investment in sustainable PPE
• Over 200 jobs announced as part of the Welsh Lighthouse Lab facility
• UK’s first medical-grade face mask manufacturing facility set to open in Cardiff
• BBI partners with Avacta Group as COVID-19 rapid antigen test manufacturer
• Northern Health Science Alliance strengthens its growing team
• Bright future for life sciences in the Midlands
• Ireland establishes first National Preclinical Imaging Centre to enhance medical research
• Abingdon Health announces its latest expansion and additional manufacturing capacity
• WMAHSN, WMCA & Medilink WM work to help support PPE supply across the region
• App to reduce the risk of falls during lockdown
• Remote blood pressure monitoring system launched for pregnant women
• Urine Testing System wins gold iF design award
• Unveiling the world’s first patient focused scalp cooling website
• Portal launched to support recruitment of overflow resource for testing of COVID-19
• Online support network for people living with heart failure
• App to help people better understand impact of social distancing
• Pioneering health project saves lives and creates capacity for the NHS in the North
• All-Party Parliamentary Group for Life Sciences relaunched to raise profile of the sector
• EIP hires new partner to strengthen medtech and healthcare practice
• Winners announced at the 2019 SEHTA MedTech Business Awards
• NHS Trusts pilot employee health and wellbeing platform
• Cambridge Science Festival launches 2020 programme
• Medilink UK appoints new CEO
• Global experts join forces to transform future health and wellbeing
• GenesisCare brings MRIdian radiotherapy to the UK
• Winners announced for MediWales Innovation Awards
• Harley Street Clinic launches state-of-the-art memory clinic
• Life science companies celebrate success at the Medilink East Midlands Business Awards
• New awards launched to shine the spotlight on STEM in Wales
• Perfectus Biomed to double workspace at Sci-Tech Daresbury
• Berwick Partners launches life sciences practice
• Bright Ideas in Health Awards winners revealed
• Medilink East Midlands welcomes its newest Patron
• BioMed Realty announces first lettings at Babraham Research Campus in Cambridge
• State of the art bioscience laboratory opens for business
• Launch of Research on Research Institute
• Global leader in microalgae industry appoints new CEO
• EKF Diagnostics opens new R&D facility
• Innovation award for Medovate
• State-of-the-art radiology department unveiled
• Health Enterprise East announces partnership
• 93-year-old surgeon shares ‘Tales of the Operating Theatre’
• First chemo patients benefit from ‘Jacqui’s Million’ funded scalp coolers
• Leading health research university joins the NHSA
• Partnership to accelerate life science businesses in the ‘golden triangle’
• Hill Dickinson becomes Medilink corporate partner
• Official launch of The Biosphere
• Eye surgeons join forces to launch innovative clinic
• Silver design success for scalp cooling expert
• Launch of Health Innovation Research Alliance Northern Ireland
• John Bell & Croyden launch private care home offering
• Creavo appoints new European Director of Sales
• Winners announced for Medilink UK Healthcare Business Awards
• New CEO for Life Sciences Hub Wales
• Cutting-edge medical software company hits 100 employee mark
• Biocatalysts win Queen’s award for Enterprise
• Renowned US hospital group takes first step in the UK
• Huntleigh wins Queen’s Award for Innovation
• Launch of National Healthcare Photonics Centre
• Grade A science park in Nottingham gets underway
• Kent Science Park opens The HUB
• PAXMAN in-line for prestigious design accolade
• New angel investor network for Birmingham
• Winners announced for SEHTA Healthcare Business Awards
• Development agreement for new London hub
• Medilink West Midlands 2018 Award winners revealed
• National award for scalp cooling technology
• Success for Health Technology Wales in first year
• Medilink East Midlands welcomes its 21st Patron
• Two medical concierge companies launch Birmingham offering at Arab Health
• Collaboration to benefit X-ray services in Leicester
• International medical pathway launched at Arab Health
• Scheme to inspire companies in Derbyshire & Nottinghamshire
• UK Health Secretary visits FutureNova
• New network to boost health innovation and business
• Winners announced for MediWales Innovation Awards
• Cryo-Electron Microscopy Facility launched
• Cardiff University opens world-class biobank
• BioHub Birmingham develops incubator to meet increasing demand

Regulation

• Digital transformation – Are virtual audits the new normal?
• Data: Which Direction? – The current reforms and how we got here!
• MHRA publishes guidance to support bringing e-cigarettes to market as licensed therapies 
• Medovate expands product range with CE Mark Regulatory Approvals
• Vinehealth Cancer Platform receives medical device CE mark certification
• UK life sciences regulation begins to diverge – The Medicines and Medical Devices Bill
• What does Brexit mean for your Intellectual Property (IP) rights?
• EU MDR and IVDR: impact on combination products and companion diagnostics

Uncategorized